Time for a Bold New Vision at the Stop TB Partnership
From The Lancet, Volume 376, Issue 9749, Pages 1283 - 1284, 16 October 2010 Salmaan Keshavjee,a,b,c Francoise Girard,d Mark Harrington,e Paul E Farmera,b,c Tuberculosis—a curable infectious disease—continues to cause illness in more than 9 million people annually. In the past…
2010 Pipeline Report
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, Immune-based therapies, and Preventive Technologies in Development. By Polly Clayden, Lei Chou, Simon Collins, Mark Harrington, Richard Jefferys, Eleonora Jimenez, Scott Morgan, Tracy Swan, Javid Syed and Claire Wingfield.
2009 Report on TB Research Funding Trends
2009 TB Research Funding Trends, 2005 - 2008 - Second Edition March 2010 - This is an update to Treatment Action Group’s 2009 report on funding trends for tuberculosis (TB) research and development (R&D) from the baseline year 2005 through…
Monitoring TB/HIV Indicators for UNGASS: Kenya, Uganda and Zambia
January 2010 - Despite being curable, Tuberculosis (TB) continues to be the leading cause of death among people with HIV in 2008, accounting for 25% of all HIV-related deaths. The World Health Organization (WHO) has developed a 12-point policy package…
Empowering Communities for TB Advocacy: The TAG-ICW Model
2009 This publication by TAG and the International Community of Women Living with HIV–Eastern Africa (ICW) provides activists, policy makers, and donors with lessons learned from two years of capacity building for HIV treatment activists to integrate tuberculosis (TB) and…
TAG at the Union: Addressing Critical Challenges in TB/HIV Research & Program Implementation
Addressing Critical Challenges in TB/HIV Research & Program Implementation 1 December 2009, Cancun, Mexico Introduction About 70 activists, researchers, clinicians and public health experts participated in a TAG/Stop TB Partnership satellite meeting held prior to the 40th Union World Conference…
2009 Pipeline Report
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, and Microbicides in Development July 2009 By Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Javid Syed, and Claire Wingfield TAG’s annual Pipeline Reportsurveys the developments in medicines and diagnostics most likely…
2008 Report on TB Research Funding Trends
Tuberculosis Research & Development: A Critical Analysis of Funding Trends, 2005–2007: An Update By Neha Agarwal May 2009 - For the third year, Treatment Action Group (TAG) analyzes and reports on the annual funding of tuberculosis (TB ) research and…